tag:blogger.com,1999:blog-1943747492836761036Thu, 26 Jan 2012 09:07:00 +0000ethicsHealthcare decision making FTdata matrixhumorousmedicinesBBCSocial Mediaantimicrobial resitstancecancerCounterfeitECDCResearchGasteinlife sciencesInformation to patientsfundingdeveloping countriesDG SANCOPatient SafetyMEPsafetyFDAAndrew WittyHPV VaccineEuropean Antibiotics Awareness Dayparallel tradedrug approvalantimicrobialsmalariabiotechnologygeneric pricingIPHAcounterfeit medicinesParliament MagazineMarisa MatiasdiabetesH1N1BuitenScrippatent poolsecurityantibiotic resistancepublic healthHealthcare decision makingIndia FTABrussels pressResearch and developmentSector Inquiryprice containmentCVDKroesUKGerman healthcare reform; cost containment; GermanypatentsCSRPerformance indicatorsPaul FlynnIPRLonngrenHepatitisJohn DalliSpanish PresidencyRheumatoid ArthritisVaccineaffordable; CanadatransparencyEurobarometerEVMIPHA Pharmaceutical Packagedrug developmentinnovationNHSdiseaseWHOECJEMAclinical trialsEuropean ParliamentReformfalsified medicinespolicy bloggingantimicrobial resistanceNetherlandsInnovative Medicines InitiativeInformapricingCorporate Social ResponssbilitytrustHIVEuropean CommissionHTAHealthy ageingcode of conductspaediatricsaffordablefalsified directivepricing and reimbursementWorld Diabetes DayEFPIAPatientsanimal researchsustainable accessCross-border healthcareAccesscost containmentSub Saharan Africacost containment;Access; EU - India FTAstakeholder dialogueBoseleyantibacterialsCoding projectSwedish PresidencyinternetimmunisationObamaantibiotics3RsPhRMADiffusionbiopharmaceutical industryPPPUS Healthcare reformadherencechronic diseasesIMIMBJscienceGlobal FundCodinglIDFEBEcardiovascularhttp://www.blogger.com/img/blank.giftransperency directivevaccinationEuropean VoiceSunshine Actranimal welfareEHFGPharmacoviglancechildren healthFTPandemicPharmaceutical PackageEFPIA Annual Meetings 2010ABPIParliamentGnereal Meetinghealthcareintellectual property2D barcodeHorizon 2020Alzheimer’smass-serialisationvaccinesUSDG COMPaccess to medicinesalternativeshealthpubli-private partnershipsPandemic preparednessCouncil of EuropeEFPIA represents the pharmaceutical industry operating in Europe. Through its direct membership of 31 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 2,200 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.http://efpia.blogspot.com/noreply@blogger.com (EFPIA)Blogger335125tag:blogger.com,1999:blog-1943747492836761036.post-8651542062442097214Thu, 26 Jan 2012 09:07:00 +00002012-01-26T10:07:00.622+01:00Counterfeitcounterfeit medicinesfalsified medicinesPatient Safetyfalsified directivesafetyRead below the joint press release below on the developement of  a practical and cost-effective solution to implement the requirements of the Falsified Medicines Directive in Europe: The European Stakeholder Model (ESM) Joint Press Release EDQM 260112 (function() { var scribd = document.createElement("script"); scribd.type = "text/javascript"; scribd.async = true; scribd.src = "http://http://efpia.blogspot.com/2012/01/press-release-eaepc-efpia-girp-pgeu.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-6584234770642831271Wed, 25 Jan 2012 16:26:00 +00002012-01-25T17:27:38.086+01:00chronic diseasesdiabetes Currently 32 million people in the EU have diabetes, withthis figure set to grow to 38.3 million by 2030. Treating diabetes and its complications takes up between 10% and 18.5% of EU member States healthcare budgets.  According to a new study released today by London School of Economics (LSE), the rise in diabetes prevalence is driven by: Increasing obesity, Ageing populations http://efpia.blogspot.com/2012/01/study-burden-of-diabetes-in-europe.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-1457475963786773848Mon, 23 Jan 2012 14:27:00 +00002012-01-23T15:28:07.209+01:00 BBC News: "Fake malaria drugs could put million at risk". The Daily Telegraph: "The battle to discover new antibiotics". World Economic Forum Blog: "Global risks 2012: What if antibiotics stopped working?" Pharma Times: "Generics market to boom as blockbuster go off-patent". Inpharm: "The work of NICE international". The Economist: "The battle of the bulge". The Guardian Health Blog: "WHO http://efpia.blogspot.com/2012/01/what-we-are-reading-this-week_23.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-3835941751644649876Thu, 19 Jan 2012 14:53:00 +00002012-01-19T15:55:56.524+01:00Counterfeitcounterfeit medicinesfalsified medicinesfalsified directiveCouncil of Europe EFPIA welcomes the MEDICRIME Convention launched by the Council of Europe in December 2010 and opened for signature on 28 November 2011 at a high-level conference in Moscow. EFPIA supports the Convention’s broad definition of counterfeit medicinal products, i.e. “products where a false representation has been made as regards identity and/or source”. The Convention provides that sanctions http://efpia.blogspot.com/2012/01/efpia-supports-medicrime-convention.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-8393500618580811420Mon, 16 Jan 2012 14:33:00 +00002012-01-16T15:33:09.868+01:00   In-Pharma Technologist: "US fake drug seizures up 200%" . Pharma Times: "US proposals for pharma supply chain integrity". Bloomberg: "Greek crisis has pharmacists pleading for aspirin as drug supply dries up". Pharmaceutical Executive: "Europe: Patient safety first" The Financial: "EFPIA fully behind the idea of a European Council for Health". Pharmaceutical Marketing Europe: "The http://efpia.blogspot.com/2012/01/what-we-are-reading-this-week.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-810097579466992994Thu, 12 Jan 2012 15:09:00 +00002012-01-12T17:11:59.026+01:00Counterfeitcounterfeit medicinesPatient Safetysecuritysafety This month has seen the publication of an article from EFPIA in Pharmaceutical Executive Magazine on a verification system to ensure the safety of the supply chain in Europe. EFPIA together with GIRP (Groupement International de la Répartition Pharmaceutique) and PGEU (Pharmaceutical Group of the European Union), the respective European organisations of wholesalers and pharmacists at EU http://efpia.blogspot.com/2012/01/coding-project-europe-patient-safety.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-8904414590971321538Mon, 09 Jan 2012 15:42:00 +00002012-01-09T16:43:22.778+01:00FDASocial MediaInformation to patients The US Food and Drug Administration (FDA) has finally issued some guidance on the pharmceutical industry's use of social media. Two years after carrying a major public hearing on the topic, the FDA released a new draft guidance that offers recommandations to companies wishing to respond to unsolicited for off-labels information, includind requests made via social media websites. The http://efpia.blogspot.com/2012/01/fda-draft-social-media-guidance-for-off.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-3111437638460543830Tue, 20 Dec 2011 16:02:00 +00002011-12-20T17:02:33.334+01:00 EFPIA is closed from 12:30 on Wednsday 21 December 2011 until 8:30am on Tuesday 3 January 2012. http://efpia.blogspot.com/2011/12/efpia-sends-you-their-seasons-greetings.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-5024052788749253360Tue, 20 Dec 2011 15:37:00 +00002011-12-20T16:54:09.058+01:00animal researchResearchanimal welfare <p><br><br><br>lll</p> Novo Nordisk is to stop the use of living animals to test the quality of batches of medicines produced by the company. The commitment has been http://efpia.blogspot.com/2011/12/video-limit-use-of-animal-research.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-2981688182057691143Mon, 19 Dec 2011 11:15:00 +00002011-12-19T14:38:41.759+01:00 Reuters: "Fitch: Pharmceuticals outlook 2012 negative". Pharma Times: "Tough 2012 for pharma industry still rated highly". Pharma Manufacturing: "Why buisness of fake medicines is booming". In-Pharma Technologist: "Drug quality treaty needed to raise standards, academics say". Pharma Times: "Italy announces reimbursement for innovative new drugs". Pharmaceutical Technology: "Impact of ageinghttp://efpia.blogspot.com/2011/12/what-we-are-reading-this-week_19.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-5813979005828507714Wed, 14 Dec 2011 14:29:00 +00002011-12-15T14:07:27.665+01:00Innovative Medicines Initiativeaccess to medicinesmedicinesantibioticsResearchinnovationhealthResearch and developmentscience "We need to help our scientists, whether they are in industry or outside, to make sure that whatever comes out of that is going to reach the patients". Richard Bergström, EFPIA Director-General.  Last week, Richard Bergström, EFPIA Director-General gave a lecture in Brussels entitled  "Is society ready for the new science?" The lecture attracted an excellent turnout, with more http://efpia.blogspot.com/2011/12/event-efpia-director-general-lecture-is.htmlnoreply@blogger.com (EFPIA)0tag:blogger.com,1999:blog-1943747492836761036.post-8481556034243761982Mon, 12 Dec 2011 12:45:00 +00002011-12-12T13:45:24.471+01:00 Gabi: "EU investigation tackles pay-for-delay". PMLive: "European pharma industry calls for robust HTA framework". Le Nouvel Economiste: "Laboratoires pharmaceutiques – La falaise des brevets" Pharmaceutical Technology: "European action against antimicrobial resistance". Pharma Times: "Europeans prefer info from drigmakers direct, not on Twitter". Euractiv: "Italy, Spain, could drop http://efpia.blogspot.com/2011/12/what-we-are-reading-this-week_12.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-3384564001188684446Thu, 08 Dec 2011 12:37:00 +00002011-12-12T13:46:00.097+01:00HTAThe Healthcare Industry is pleased to present today in the setting of the EUnetHTA Joint Action Conference in Gdansk, a jointly developed position paper on ‘The value of industry involvement in HTA’. See the paper below: FINAL the Value of Industry Involvement in HTA 011211-20111205-008-En-V1 (function() { var scribd = document.createElement("script"); scribd.type = "text/javascript"; http://efpia.blogspot.com/2011/12/press-release-joint-healthcare-industry.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-466131497477152448Wed, 07 Dec 2011 10:33:00 +00002011-12-07T12:02:51.501+01:00   Tomorrow, Thursday 8 December, Richard Bergtröm, EFPIA Director-General will give a lecture in Brussels on the great challenges of the pharmaceutical industry through the following theme:  Is society ready for the new science? If you would like to attend send an e-mail to event@efpia.org http://efpia.blogspot.com/2011/12/tomorrow-thursday-8-december-richard.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-6022310875422985246Tue, 06 Dec 2011 11:40:00 +00002011-12-06T12:48:23.791+01:00ResearchHTA Richard Bergström, EFPIA Director-General says: "We agree with the BioMed Alliance that success and innovation in health research requires a long-term commitment.  I warmly welcome this initiative, which is a step towards a European “National Institute of Health”. Such a European body would allow both strategic long-term planning driven by healthcare needs and optimising healthcare http://efpia.blogspot.com/2011/12/press-statement-efpia-fully-behind-idea.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-1382981814884501194Mon, 05 Dec 2011 09:36:00 +00002011-12-05T14:24:55.947+01:00 Copyright: ArtByChrysti Science Business: "Horizon 2020: The views in Brussels". Pharma Times: "EFPIA welcomes partnership commitment in Horizon 2020 proposal". Inpharm: "Europe's €80 billion will support research". PMLive: "EC unveils €80bn R&D investment programme". Global: "La Efpia elogia el marco de colaboración Horizon 2020".   PMLive: "Novo Nordisk to limit use of animal http://efpia.blogspot.com/2011/12/what-we-are-reading-this-week.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-7640710536262673870Wed, 30 Nov 2011 15:50:00 +00002011-12-01T16:15:30.868+01:00MEPEuropean ParliamentParliament Magazinecounterfeit medicinesMarisa Matiasfalsified directive Credit: Fabrice Debatty Photography It is the third year EFPIA is sponsoring the Parliament Magazine's MEP Award. On Tuesday 29 November, Richard Bersgtröm, EFPIA Director General was pleased to hand the Health MEP Award to Marisa Matias from the GUE party. Marisa Matias was rewarded  for her commitment in pharmaceutical and health issues. She has been rapporteur on the Falsified http://efpia.blogspot.com/2011/11/parliament-magazine-mep-award-2011.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-3337438925731911019Wed, 30 Nov 2011 10:04:00 +00002011-11-30T12:51:06.579+01:00PPPInnovative Medicines Initiativepubli-private partnershipsResearchHorizon 2020innovationIMI Today the European Commission launched a new Framework for Research and Innovation: Horizon 2020. As Richard Bergström, EFPIA's Director-General says: "The European Commission should be commended for their intention to further develop public-private partnerships (PPP). There is shared understanding that private companies and public bodies must collaborate more and to think about new http://efpia.blogspot.com/2011/11/press-release-horizon-2020-new-research.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-6105961186882047943Mon, 28 Nov 2011 11:17:00 +00002011-11-28T14:05:29.786+01:00 Reuters: "Returns on R&D tumble at world's top drugmakers". Pharma Times: "Pharma groups welcome landmark EU Court ruling". Bloomberg: "EU Court backs longer patent protection for combines drugs".  In-Pharma Technologist: "EC seeks industry feedbcak to shape serialisation". Slate.com: "Lab mice: Are they limiting our understanding of human disease?" IP-Watch: "10 years of TRIPS and http://efpia.blogspot.com/2011/11/what-we-are-reding-this-week.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-2150029307506098951Mon, 21 Nov 2011 09:38:00 +00002011-11-21T14:01:40.078+01:00 Reuters: "Europe kick-starts R&D fightback against superbugs". Inpharm: "Industry supports bid to revitalise antibiotich research". PharmaTimes: "Real action required to tackle antibiotic resistance". The Daily Telegraph: "Superbugs are becoming untreatable, doctors warn". BBC News: "Action on antibiotics".   Fierce Biotech: " EC outlines new incentives to spur antibiotic R&D". http://efpia.blogspot.com/2011/11/what-we-are-reading-this-week_21.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-6263918510094239602Wed, 16 Nov 2011 16:38:00 +00002011-11-17T16:06:58.907+01:00antibacterialsantibiotic resistancepublic healthantibiotics Today, the European Commission published its "Strategy and Action Plan to Tackle the Threat of Antibiotic Resistance." The power of antibiotic therapy resulted in nothing less than a total revolution in the practice of medicine. Antibiotics fundamentally transformed the profession from a diagnostic, non-interventional field to a therapeutic, interventional profession.  Antibiotic resistance http://efpia.blogspot.com/2011/11/efpia-supports-kick-start-process-to.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-3364173982455759989Mon, 14 Nov 2011 09:43:00 +00002012-01-23T15:00:28.040+01:00IDFchronic diseasesWorld Diabetes DayWHOdiabetes World Diabetes Day raises global awareness of diabetes According to the International Diabetes Federation (IDF) in 2011, 366 million people have diabetes and by 2030 this will have risen to 552 million. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. http://efpia.blogspot.com/2011/11/today-it-is-world-diabetes-day.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-8692601870983081565Mon, 14 Nov 2011 08:57:00 +00002011-11-14T12:48:49.290+01:00 Reuters: "Europe's crisis spells more pain for drugmakers". Inpharm: "Market access -- looking back". Gabi: "Some relief from drug shortages in the US". Pharmalot: "EMA is investigated over conflict of interest". http://efpia.blogspot.com/2011/11/what-we-are-reading-this-week_14.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-874769647843557920Mon, 07 Nov 2011 12:52:00 +00002011-11-07T13:52:26.913+01:00   Euractiv: "EU's ethical business blueprint raises expectations". Fierce Bioteh: "VC drought for biotech hits hard in Europe with 44% drop in 3 investement". Gabi: "Obam's fresh attempts to ease drugs shortages in the US". http://efpia.blogspot.com/2011/11/what-we-are-reading-this-week.htmlnoreply@blogger.com (EFPIA Blogger)0tag:blogger.com,1999:blog-1943747492836761036.post-6858635960735158186Thu, 03 Nov 2011 10:25:00 +00002011-11-03T11:25:01.585+01:00public healthvaccinationSocial Mediaimmunisationvaccines Immunization and social media:  Watch below a Sanofi Pasteur video, nicely done, on how social media is changing the way we communicate and see the world. This video shows how the world is changing and how the debate is now happening on social media, taking as an example the 2009 H1N1 flu pandemic and the critics around vaccination that followed. "Social networking is changing the way http://efpia.blogspot.com/2011/11/video-decision-making-in-immunization.htmlnoreply@blogger.com (EFPIA Blogger)0